SARS-CoV-2 pneumonia with subcutaneous emphysema, mediastinal emphysema, and pneumothorax: A case report
Conclusions:
Subcutaneous emphysema and pneumothorax may occur in patients with SARS-CoV-2 pneumonia and chronic pulmonary disease. Chronic cardiac disease might be aggravated by SARS-CoV-2 infection, and develop heart failure.
Source: Medicine - Category: Internal Medicine Tags: Research Article: Clinical Case Report Source Type: research
More News: Antiviral Therapy | Cardiology | Coronavirus | COVID-19 | Emphysema | Heart | Heart Failure | Intensive Care | Internal Medicine | Laboratory Medicine | Liver | PET Scan | Pneumonia | Pneumothorax | Respiratory Medicine | SARS | Urology & Nephrology